Bioactive Compounds Against SARS-CoV-2
Bioactive Compounds Against SARS-CoV-2
Chen, Jen-Tsung
Taylor & Francis Ltd
09/2023
276
Dura
Inglês
9781032347998
15 a 20 dias
Descrição não disponível.
Chapter 1 - Omics-guided intervention strategies in combatting SARS-CoV-2: Recent advancements and challenges
Chapter 2 - The application of computer-aided drug design methods for developing natural compounds-based therapeutics against SARS-CoV-2
Chapter 3 - Therapeutic targets of host factors for potential COVID-19 treatments
Chapter 4 - Phytocompounds: A paradigm shift as therapeutics for COVID-19
Chapter 5 - Flavonoids as potential therapeutic agents against the SARS-CoV-2 infection: An overview
Chapter 6 - Antiviral activities of flavonoids against COVID-19 and other virus-causing ailments
Chapter 7 - Potential therapeutic effects of flavonoids against the COVID-19 infection: The mode of action
Chapter 8 - Terpene and Terpenoid: Potent antiviral agents against SARS-CoV-2
Chapter 9 - Phytonutrients and secondary metabolites to cease SARS-CoV-2 loop
Chapter 10 - Treatment strategies against COVID-19 using bioactive compounds and plant secondary metabolites
Chapter 11 - The potential contribution of vitamin K as a nutraceutical to scale down the mortality rate of COVID-19
Chapter 12 - Gastrointestinal Symptoms in COVID-19 patients: Prevention and Treatment
Chapter 13 - Mechanisms and management options of liver injury in COVID19: A Review
Chapter 14 - Marine species-derived bioactives against coronavirus disease
Chapter 15 - Potential bioactive compounds of Indian flora against SARS-CoV-2
Chapter 16 - Natural product-derived active compounds for the management of COVID-19: A summary from Indochina
Chapter 17 - Novel therapeutic strategy based on nanomedicine targeting thrombosis for SARSCoV-2
Chapter 18 - Nanomaterials in combating human coronavirus infections
Chapter 19 - Structural insights into drug targets from MERS, SARS-CoV, and SARS-CoV-2 and scope for phytochemicals as broad-spectrum anti-virals and immunomodulators.
Chapter 20 - Precision phytochemicals for COVID-19-induced olfactory dysfunction
Chapter 2 - The application of computer-aided drug design methods for developing natural compounds-based therapeutics against SARS-CoV-2
Chapter 3 - Therapeutic targets of host factors for potential COVID-19 treatments
Chapter 4 - Phytocompounds: A paradigm shift as therapeutics for COVID-19
Chapter 5 - Flavonoids as potential therapeutic agents against the SARS-CoV-2 infection: An overview
Chapter 6 - Antiviral activities of flavonoids against COVID-19 and other virus-causing ailments
Chapter 7 - Potential therapeutic effects of flavonoids against the COVID-19 infection: The mode of action
Chapter 8 - Terpene and Terpenoid: Potent antiviral agents against SARS-CoV-2
Chapter 9 - Phytonutrients and secondary metabolites to cease SARS-CoV-2 loop
Chapter 10 - Treatment strategies against COVID-19 using bioactive compounds and plant secondary metabolites
Chapter 11 - The potential contribution of vitamin K as a nutraceutical to scale down the mortality rate of COVID-19
Chapter 12 - Gastrointestinal Symptoms in COVID-19 patients: Prevention and Treatment
Chapter 13 - Mechanisms and management options of liver injury in COVID19: A Review
Chapter 14 - Marine species-derived bioactives against coronavirus disease
Chapter 15 - Potential bioactive compounds of Indian flora against SARS-CoV-2
Chapter 16 - Natural product-derived active compounds for the management of COVID-19: A summary from Indochina
Chapter 17 - Novel therapeutic strategy based on nanomedicine targeting thrombosis for SARSCoV-2
Chapter 18 - Nanomaterials in combating human coronavirus infections
Chapter 19 - Structural insights into drug targets from MERS, SARS-CoV, and SARS-CoV-2 and scope for phytochemicals as broad-spectrum anti-virals and immunomodulators.
Chapter 20 - Precision phytochemicals for COVID-19-induced olfactory dysfunction
Este título pertence ao(s) assunto(s) indicados(s). Para ver outros títulos clique no assunto desejado.
immunomodulatory mechanisms;viral mutation resistance;phytochemical therapeutics;host-pathogen interactions;nutraceutical interventions;omics-based analysis;plant-derived antiviral strategies
Chapter 1 - Omics-guided intervention strategies in combatting SARS-CoV-2: Recent advancements and challenges
Chapter 2 - The application of computer-aided drug design methods for developing natural compounds-based therapeutics against SARS-CoV-2
Chapter 3 - Therapeutic targets of host factors for potential COVID-19 treatments
Chapter 4 - Phytocompounds: A paradigm shift as therapeutics for COVID-19
Chapter 5 - Flavonoids as potential therapeutic agents against the SARS-CoV-2 infection: An overview
Chapter 6 - Antiviral activities of flavonoids against COVID-19 and other virus-causing ailments
Chapter 7 - Potential therapeutic effects of flavonoids against the COVID-19 infection: The mode of action
Chapter 8 - Terpene and Terpenoid: Potent antiviral agents against SARS-CoV-2
Chapter 9 - Phytonutrients and secondary metabolites to cease SARS-CoV-2 loop
Chapter 10 - Treatment strategies against COVID-19 using bioactive compounds and plant secondary metabolites
Chapter 11 - The potential contribution of vitamin K as a nutraceutical to scale down the mortality rate of COVID-19
Chapter 12 - Gastrointestinal Symptoms in COVID-19 patients: Prevention and Treatment
Chapter 13 - Mechanisms and management options of liver injury in COVID19: A Review
Chapter 14 - Marine species-derived bioactives against coronavirus disease
Chapter 15 - Potential bioactive compounds of Indian flora against SARS-CoV-2
Chapter 16 - Natural product-derived active compounds for the management of COVID-19: A summary from Indochina
Chapter 17 - Novel therapeutic strategy based on nanomedicine targeting thrombosis for SARSCoV-2
Chapter 18 - Nanomaterials in combating human coronavirus infections
Chapter 19 - Structural insights into drug targets from MERS, SARS-CoV, and SARS-CoV-2 and scope for phytochemicals as broad-spectrum anti-virals and immunomodulators.
Chapter 20 - Precision phytochemicals for COVID-19-induced olfactory dysfunction
Chapter 2 - The application of computer-aided drug design methods for developing natural compounds-based therapeutics against SARS-CoV-2
Chapter 3 - Therapeutic targets of host factors for potential COVID-19 treatments
Chapter 4 - Phytocompounds: A paradigm shift as therapeutics for COVID-19
Chapter 5 - Flavonoids as potential therapeutic agents against the SARS-CoV-2 infection: An overview
Chapter 6 - Antiviral activities of flavonoids against COVID-19 and other virus-causing ailments
Chapter 7 - Potential therapeutic effects of flavonoids against the COVID-19 infection: The mode of action
Chapter 8 - Terpene and Terpenoid: Potent antiviral agents against SARS-CoV-2
Chapter 9 - Phytonutrients and secondary metabolites to cease SARS-CoV-2 loop
Chapter 10 - Treatment strategies against COVID-19 using bioactive compounds and plant secondary metabolites
Chapter 11 - The potential contribution of vitamin K as a nutraceutical to scale down the mortality rate of COVID-19
Chapter 12 - Gastrointestinal Symptoms in COVID-19 patients: Prevention and Treatment
Chapter 13 - Mechanisms and management options of liver injury in COVID19: A Review
Chapter 14 - Marine species-derived bioactives against coronavirus disease
Chapter 15 - Potential bioactive compounds of Indian flora against SARS-CoV-2
Chapter 16 - Natural product-derived active compounds for the management of COVID-19: A summary from Indochina
Chapter 17 - Novel therapeutic strategy based on nanomedicine targeting thrombosis for SARSCoV-2
Chapter 18 - Nanomaterials in combating human coronavirus infections
Chapter 19 - Structural insights into drug targets from MERS, SARS-CoV, and SARS-CoV-2 and scope for phytochemicals as broad-spectrum anti-virals and immunomodulators.
Chapter 20 - Precision phytochemicals for COVID-19-induced olfactory dysfunction
Este título pertence ao(s) assunto(s) indicados(s). Para ver outros títulos clique no assunto desejado.